A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.
Salazar R, Capdevila J, Laquente B, Manzano JL, Pericay C, Villacampa MM, López C, Losa F, Safont MJ, Gómez A, Alonso V, Escudero P, Gallego J, Sastre J, Grávalos C, Biondo S, Palacios A, Aranda E.
Salazar R, et al.
BMC Cancer. 2015 Feb 26;15:60. doi: 10.1186/s12885-015-1053-z.
BMC Cancer. 2015.
PMID: 25886378
Free PMC article.
Clinical Trial.